Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

MAB011-A/13 Anti-Apolipoprotein A-I Antibody, clone A/13

Anti-Apolipoprotein A-I Antibody, clone A/13 detects level of Apolipoprotein A-I & has been published & validated for use in ELISA, RIA.

Anti-Apolipoprotein A-I Antibody, clone A/13: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.
Research Category: Metabolism Research Sub-Category: Lipid Metabolism & Weight Regulation Gene Symbol: APOA1, ApoA-I, preproapolipoprotein, amyloidosis, MGC117399, Apo-AI UniProt Number: P02647
MAB011-A/13
250 µg  
Purchase on Sigma-Aldrich

Offerte speciali

Panoramica

Replacement Information

Offerte speciali

100% Performance Guaranteed

Tabella delle specifiche principali

Species ReactivityKey ApplicationsHostFormatAntibody Type
HELISA, RIAMPurifiedMonoclonal Antibody
Description
Catalogue NumberMAB011-A/13
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-Apolipoprotein A-I Antibody, clone A/13
Alternate Names
  • ApoAI
References
Product Information
FormatPurified
PresentationIgG fraction purified from mouse ascites by DEAE column chromatography. In 0.015 M potassium phosphate buffer with 0.15M NaCl, 0.1% sodium azide, pH 7.2.
Quality LevelMQ100
Applications
ApplicationAnti-Apolipoprotein A-I Antibody, clone A/13 detects level of Apolipoprotein A-I & has been published & validated for use in ELISA, RIA.
Key Applications
  • ELISA
  • Radioimmunoassay
Application NotesCompetitive RIA or EIA

Optimal working dilutions must be determined by the end user.
Biological Information
ImmunogenPurified human plasma Apo A-I.
CloneA/13
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostMouse
SpecificityApolipoprotein A-I. No cross reactivity to Apo A-II or Apo B.

AFFINITY CONSTANT: 8 x 10E9 L/mol
IsotypeIgG1
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis.
Gene Symbol
  • APOA1
  • ApoA-I
  • preproapolipoprotein
  • amyloidosis
  • MGC117399
  • Apo-AI
UniProt Number
UniProt SummaryFUNCTION: SwissProt: P02647 # Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT).
SIZE: 267 amino acids; 30778 Da
SUBUNIT: Interacts with APOA1BP.
SUBCELLULAR LOCATION: Secreted.
TISSUE SPECIFICITY: Major protein of plasma HDL, also found in chylomicrons. Synthesized in the liver and small intestine.
PTM: Palmitoylated.
DISEASE: SwissProt: P02647 # Defects in APOA1 are a cause of high density lipoprotein deficiency type 2 (HDLD2) [MIM:604091]; also known as familial hypoalphalipoproteinemia (FHA). Inheritance is autosomal dominant. & Defects in APOA1 are a cause of the low HDL levels observed in high density lipoprotein deficiency type 1 (HDLD1) [MIM:205400]; also known as analphalipoproteinemia or Tangier disease (TGD). HDLD1 is a recessive disorder characterized by the absence of plasma HDL, accumulation of cholesteryl esters, premature coronary artery disease, hepatosplenomegaly, recurrent peripheral neuropathy and progressive muscle wasting and weakness. In HDLD1 patients, ApoA-I fails to associate with HDL probably because of the faulty conversion of pro-ApoA-I molecules into mature chains, either due to a defect in the converting enzyme activity or a specific structural defect in Tangier ApoA-I. & Defects in APOA1 are a cause of systemic non-neuropathic amyloidosis [MIM:105200]; also known as amyloidosis VIII or Ostertag-type amyloidosis. It is an autosomal dominant disorder characterized by generalized amyloid deposition.
SIMILARITY: SwissProt: P02647 ## Belongs to the apolipoprotein A1/A4/E family.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain at -20°C in undiluted aliquots for up to 12 months. Do not store below -20°C or in dry ice as precipitation may occur. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size250 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
MAB011-A/13 04053252614804